Physician profile
Cheryl E Alderson
NPI 1366521809
$5,920.41
in general payments reported to CMS, 2019-2025
16 companies · $898 in 2025
The $898 reported for 2025 was more than what 89% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $825 · 2020: $124 · 2021: $2,725 · 2022: $235 · 2023: $411 · 2024: $702 · 2025: $898.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,011.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,011.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Welch Allyn | $2,660.00 | 2021 | |
| Sun Pharmaceutical Industries INC. | $879.43 | 2019-2025 | Bromsite, Xelpros, Cequa |
| Tarsus Pharmaceuticals, INC. | $452.16 | 2024-2025 | Xdemvy |
| Bausch & Lomb Americas INC. | $289.72 | 2023-2025 | Miebo, Xiidra, Vyzulta |
| Coopervision INC. | $275.70 | 2020-2025 | Misight Contact Lens, Onefit Contact Lens |
| Allergan, INC. | $232.86 | 2019 | |
| Alcon Vision LLC | $228.09 | 2022-2025 | Dailies Total1, Precision 1, Rocklatan |
| Johnson & Johnson Vision Care, INC. | $208.84 | 2019-2025 | Acuvue |
| Shire North American Group INC | $208.75 | 2019 | |
| Oyster Point Pharma, INC. | $143.73 | 2023-2025 | Tyrvaya |
| Dompe US, INC. | $142.73 | 2025 | Oxervate |
| Abbvie INC. | $57.93 | 2022 | |
| Carl Zeiss Meditec, INC. | $55.56 | 2019 | |
| Sight Sciences, INC. | $43.81 | 2021 | |
| Novartis Pharmaceuticals Corporation | $21.70 | 2023 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Carl Zeiss Meditec Ag | $19.40 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cheryl Alderson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.